Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 4/2008

01-04-2008 | Letter to the editor

Reactivation of hepatitis B virus during rituximab treatment of a patient with follicular lymphoma

Authors: Shih-Hung Yang, Sung-Hsin Kuo

Published in: Annals of Hematology | Issue 4/2008

Login to get access

Excerpt

Dear Editor, …
Literature
1.
Hoofnagle JH, Dusheiko GM, Schafer DF, Jones EA, Micetich KC, Young RC, Costa J (1982) Reactivation of chronic hepatitis B virus infection by cancer chemotherapy. Ann Intern Med 96:447–449PubMed
2.
Cheng AL, Hsiung CA, Su IJ, Chen PJ, Chang MC, Tsao CJ, Kao WY, Uen WC, Hsu CH, Tien HF, Chao TY, Chen LT, Whang-Peng J, Lymphoma Committee of Taiwan Cooperative Oncology Group (2003) Steroid-free chemotherapy decreases risk of hepatitis B virus (HBV) reactivation in HBV-carriers with lymphoma. Hepatology 37:1320–1328PubMedCrossRef
3.
Skrabs C, Muller C, Agis H, Mannhalter C, Jager U (2002) Treatment of HBV-carrying lymphoma patients with rituximab and CHOP: a diagnostic and therapeutic challenge. Leukemia 16:1884–1886PubMedCrossRef
4.
Perceau G, Diris N, Estines O, Derancourt C, Levy S, Bernard P (2006) Late lethal hepatitis B virus reactivation after rituximab treatment of low-grade cutaneous B-cell lymphoma. Br J Dermatol 155:1053–1056PubMedCrossRef
5.
Takai S, Tsurumi H, Ando K, Kasahara S, Sawada M, Yamada T, Oyama M, Moriwaki H (2005) Prevalence of hepatitis B and C virus infection in haematological malignancies and liver injury following chemotherapy. Eur J Haematol 74:158–165PubMedCrossRef
6.
Dervite I, Hober D, Morel P (2001) Acute hepatitis B in a patient with antibodies to hepatitis B surface antigen who was receiving rituximab. N Engl J Med 344:68–69PubMedCrossRef
Metadata
Title
Reactivation of hepatitis B virus during rituximab treatment of a patient with follicular lymphoma
Authors
Shih-Hung Yang
Sung-Hsin Kuo
Publication date
01-04-2008
Publisher
Springer-Verlag
Published in
Annals of Hematology / Issue 4/2008
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-007-0396-1

Other articles of this Issue 4/2008

Annals of Hematology 4/2008 Go to the issue

Letter to the editor

A case of concomitant autosomal recessive osteopetrosis and G6PD deficiency

Letter to the Editor

False positive PET scanning caused by inactivated influenza virus vaccination during complete remission from anaplastic T-cell lymphoma

Letter to the editor

Hydatid cyst mimicking acute chest syndrome in a sickle thalassemia patient

Original Article

Diagnostic yield of bronchoscopy with bronchoalveolar lavage in febrile patients with hematologic malignancies and pulmonary infiltrates

Original Article

Increased platelet, leukocyte, and coagulation activation in primary myelofibrosis

Letter to the editor

Large gastrosplenic fistula after effective treatment of abdominal diffuse large-B-cell lymphoma
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits